{"id":"https://openalex.org/W3121664580","doi":"https://doi.org/10.1186/s13063-020-05009-3","title":"A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia","display_name":"A master protocol to investigate a novel therapy acetyl-l-leucine for three ultra-rare neurodegenerative diseases: Niemann-Pick type C, the GM2 gangliosidoses, and ataxia telangiectasia","publication_year":2021,"publication_date":"2021-01-22","ids":{"openalex":"https://openalex.org/W3121664580","doi":"https://doi.org/10.1186/s13063-020-05009-3","mag":"3121664580","pmid":"https://pubmed.ncbi.nlm.nih.gov/33482890","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/7821839"},"language":"en","primary_location":{"id":"doi:10.1186/s13063-020-05009-3","doi":"https://doi.org/10.1186/s13063-020-05009-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13063-020-05009-3","pdf_url":"https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-020-05009-3","source":{"id":"https://openalex.org/S109512841","display_name":"Trials","issn_l":"1745-6215","issn":["1745-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-020-05009-3","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028643673","display_name":"Taylor Fields","orcid":"https://orcid.org/0000-0001-9506-4055","observed_orcids":["https://orcid.org/0000-0001-9506-4055"]},"institutions":[{"id":"https://openalex.org/I4405268044","display_name":"IntraBio Inc. (United States)","ror":"https://ror.org/05hfq4k54","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268044"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"T. Fields","raw_affiliation_strings":["IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK. tfields@intrabio.com","IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK"],"raw_orcid":"https://orcid.org/0000-0001-9506-4055","affiliations":[{"raw_affiliation_string":"IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK. tfields@intrabio.com","institution_ids":["https://openalex.org/I4405268044"]},{"raw_affiliation_string":"IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK","institution_ids":["https://openalex.org/I4405268044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5041731466","display_name":"Marc C. Patterson","orcid":"https://orcid.org/0000-0002-1116-126X","observed_orcids":["https://orcid.org/0000-0002-1116-126X"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Patterson","raw_affiliation_strings":["Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, 200 First Street SW, Rochester, MN, 55905, USA","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5066632194","display_name":"Tatiana Br\u00e9mov\u00e0-Ertl","orcid":"https://orcid.org/0000-0002-7397-045X","observed_orcids":["https://orcid.org/0000-0002-7397-045X"]},"institutions":[{"id":"https://openalex.org/I118564535","display_name":"University of Bern","ror":"https://ror.org/02k7v4d05","country_code":"CH","type":"education","lineage":["https://openalex.org/I118564535"]},{"id":"https://openalex.org/I2801112126","display_name":"University Hospital of Bern","ror":"https://ror.org/01q9sj412","country_code":"CH","type":"healthcare","lineage":["https://openalex.org/I2801112126"]}],"countries":["CH"],"is_corresponding":false,"raw_author_name":"T. Bremova-Ertl","raw_affiliation_strings":["Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology, Inselspital, University Hospital Bern and University of Bern, Bern, Switzerland","institution_ids":["https://openalex.org/I118564535","https://openalex.org/I2801112126"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109292812","display_name":"Glyn Belcher","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"G. Belcher","raw_affiliation_strings":["PV Consultancy, 113 St Georges Square Mews, London, SW1V 3RZ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"PV Consultancy, 113 St Georges Square Mews, London, SW1V 3RZ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5076853176","display_name":"Ian Billington","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268044","display_name":"IntraBio Inc. (United States)","ror":"https://ror.org/05hfq4k54","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268044"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"I. Billington","raw_affiliation_strings":["IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK","institution_ids":["https://openalex.org/I4405268044"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5013996756","display_name":"Grant C. Churchill","orcid":"https://orcid.org/0000-0001-9591-9391","observed_orcids":["https://orcid.org/0000-0001-9591-9391"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"G. C. Churchill","raw_affiliation_strings":["Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113746892","display_name":"W. Davis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210147851","display_name":"A-T Society","ror":"https://ror.org/04tw1mp85","country_code":"GB","type":"other","lineage":["https://openalex.org/I4210147851"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"W. Davis","raw_affiliation_strings":["Ataxia-Telangiectasia Society, Rothamsted Experimental Station West Common, Harpenden, AL5 2JQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ataxia-Telangiectasia Society, Rothamsted Experimental Station West Common, Harpenden, AL5 2JQ, UK","institution_ids":["https://openalex.org/I4210147851"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103269965","display_name":"William R.H. Evans","orcid":"https://orcid.org/0000-0003-0337-1221","observed_orcids":["https://orcid.org/0000-0003-0337-1221"]},"institutions":[{"id":"https://openalex.org/I142263535","display_name":"University of Nottingham","ror":"https://ror.org/01ee9ar58","country_code":"GB","type":"education","lineage":["https://openalex.org/I142263535"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"W. Evans","raw_affiliation_strings":["Niemann-Pick UK, Vermont House, Concord, Washington, Tyne and Wear, NE37 2SQ, UK","Primary Care Stratified Medicine (PRISM) Division of Primary Care, University of Nottingham, Nottingham, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Niemann-Pick UK, Vermont House, Concord, Washington, Tyne and Wear, NE37 2SQ, UK","institution_ids":[]},{"raw_affiliation_string":"Primary Care Stratified Medicine (PRISM) Division of Primary Care, University of Nottingham, Nottingham, UK","institution_ids":["https://openalex.org/I142263535"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Flint","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268044","display_name":"IntraBio Inc. (United States)","ror":"https://ror.org/05hfq4k54","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268044"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"S. Flint","raw_affiliation_strings":["IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK","institution_ids":["https://openalex.org/I4405268044"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A. Galione","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"A. Galione","raw_affiliation_strings":["Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027147713","display_name":"Ulrich Granzer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"U. Granzer","raw_affiliation_strings":["Granzer Regulatory Consulting & Services, Kistlerhofstr. 172C, D-81379, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Granzer Regulatory Consulting & Services, Kistlerhofstr. 172C, D-81379, Munich, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061871754","display_name":"Julie Greenfield","orcid":"https://orcid.org/0000-0003-2876-4849","observed_orcids":["https://orcid.org/0000-0003-2876-4849"]},"institutions":[{"id":"https://openalex.org/I4210122083","display_name":"Ataxia UK","ror":"https://ror.org/03192vt15","country_code":"GB","type":"nonprofit","lineage":["https://openalex.org/I4210122083"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"J. Greenfield","raw_affiliation_strings":["Ataxia UK, 12 Broadbent close, London, N6 5JW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ataxia UK, 12 Broadbent close, London, N6 5JW, UK","institution_ids":["https://openalex.org/I4210122083"]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Karl","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Karl","raw_affiliation_strings":["Cure Tay-Sachs Foundation, 2409 E. Luke Avenue, Phoenix, AZ, 85016, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Cure Tay-Sachs Foundation, 2409 E. Luke Avenue, Phoenix, AZ, 85016, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"R. Kay","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Kay","raw_affiliation_strings":["RK Statistics, Brook House, Mesne Lane, Bakewell, DE45 1AL, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"RK Statistics, Brook House, Mesne Lane, Bakewell, DE45 1AL, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. Lewi","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Lewi","raw_affiliation_strings":["The Cure & Action for Tay-Sachs Foundation, 94 Milborough Crescent, Lee, London, SE12 0RW, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Cure & Action for Tay-Sachs Foundation, 94 Milborough Crescent, Lee, London, SE12 0RW, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018202398","display_name":"Toni Mathieson","orcid":"https://orcid.org/0009-0001-4681-665X","observed_orcids":["https://orcid.org/0009-0001-4681-665X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Mathieson","raw_affiliation_strings":["International Niemann-Pick Disease Alliance, Vermont House, Concord, Washington, Tyne and Wear, NE37 2SQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"International Niemann-Pick Disease Alliance, Vermont House, Concord, Washington, Tyne and Wear, NE37 2SQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":null,"display_name":"T. Meyer","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"T. Meyer","raw_affiliation_strings":["Granzer Regulatory Consulting & Services, Kistlerhofstr. 172C, D-81379, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Granzer Regulatory Consulting & Services, Kistlerhofstr. 172C, D-81379, Munich, Germany","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5084208348","display_name":"Diana Pangonis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143473","display_name":"National Tay-Sachs and Allied Diseases Association","ror":"https://ror.org/043t12z55","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210143473"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"D. Pangonis","raw_affiliation_strings":["National Tay-Sachs and Allied Disease Foundation, 2001 Beacon Street, Suite 204, Boston, MA, 02135, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Tay-Sachs and Allied Disease Foundation, 2001 Beacon Street, Suite 204, Boston, MA, 02135, USA","institution_ids":["https://openalex.org/I4210143473"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078895245","display_name":"Frances M. Platt","orcid":"https://orcid.org/0000-0001-7614-0403","observed_orcids":["https://orcid.org/0000-0001-7614-0403"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"F. M. Platt","raw_affiliation_strings":["Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmacology, University of Oxford, Mansfield Road, Oxford, OX1 3QT, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":null,"display_name":"L. Tsang","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Tsang","raw_affiliation_strings":["Arnold & Porter Kaye Scholer LLP, 25 Old Broad Street, London, EC2N 1HQ, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Arnold & Porter Kaye Scholer LLP, 25 Old Broad Street, London, EC2N 1HQ, UK","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5035871833","display_name":"C. Verburg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268044","display_name":"IntraBio Inc. (United States)","ror":"https://ror.org/05hfq4k54","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268044"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"C. Verburg","raw_affiliation_strings":["IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK","institution_ids":["https://openalex.org/I4405268044"]}]},{"author_position":"middle","author":{"id":null,"display_name":"M. Factor","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405268044","display_name":"IntraBio Inc. (United States)","ror":"https://ror.org/05hfq4k54","country_code":"US","type":"company","lineage":["https://openalex.org/I4405268044"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"M. Factor","raw_affiliation_strings":["IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"IntraBio Ltd, Begbroke Science Park, Begbroke Hill, Woodstock Road, Oxford, OX5 1PF, UK","institution_ids":["https://openalex.org/I4405268044"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078660065","display_name":"Michael Leo Strupp","orcid":"https://orcid.org/0000-0002-9544-2279","observed_orcids":["https://orcid.org/0000-0002-9544-2279"]},"institutions":[{"id":"https://openalex.org/I4405281604","display_name":"Deutsches Schwindel- und Gleichgewichtszentrum","ror":"https://ror.org/04ma31e66","country_code":"DE","type":"facility","lineage":["https://openalex.org/I3018771216","https://openalex.org/I4405281604","https://openalex.org/I8204097"]},{"id":"https://openalex.org/I8204097","display_name":"Ludwig-Maximilians-Universit\u00e4t M\u00fcnchen","ror":"https://ror.org/05591te55","country_code":"DE","type":"education","lineage":["https://openalex.org/I8204097"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"M. Strupp","raw_affiliation_strings":["Department of Neurology and German Center for Vertigo and Balance Disorders, University Hospital, Ludwig Maximilians University, Munich, Germany. michael.Strupp@med.uni-muenchen.de","Department of Neurology and German Center for Vertigo and Balance Disorders, University Hospital, Ludwig Maximilians University, Munich, Germany"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Neurology and German Center for Vertigo and Balance Disorders, University Hospital, Ludwig Maximilians University, Munich, Germany. michael.Strupp@med.uni-muenchen.de","institution_ids":["https://openalex.org/I4405281604","https://openalex.org/I8204097"]},{"raw_affiliation_string":"Department of Neurology and German Center for Vertigo and Balance Disorders, University Hospital, Ludwig Maximilians University, Munich, Germany","institution_ids":["https://openalex.org/I4405281604","https://openalex.org/I8204097"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":11,"corresponding_author_ids":["https://openalex.org/A5028643673","https://openalex.org/A5078660065"],"corresponding_institution_ids":["https://openalex.org/I4405268044","https://openalex.org/I4405281604","https://openalex.org/I8204097"],"apc_list":{"value":2290,"currency":"USD","value_usd":2290},"apc_paid":{"value":2290,"currency":"USD","value_usd":2290},"fwci":6.4586,"has_fulltext":true,"cited_by_count":41,"citation_normalized_percentile":{"value":0.97612315,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"22","issue":"1","first_page":"84","last_page":"84"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10945","display_name":"Lysosomal Storage Disorders Research","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics (clinical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11235","display_name":"Statistical Methods in Clinical Trials","score":0.00039999998989515007,"subfield":{"id":"https://openalex.org/subfields/2613","display_name":"Statistics and Probability"},"field":{"id":"https://openalex.org/fields/26","display_name":"Mathematics"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T12604","display_name":"Glycogen Storage Diseases and Myoclonus","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1303","display_name":"Biochemistry"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/n-acetyl-l-leucine","display_name":"N-acetyl-L-leucine","score":0.9259999990463257},{"id":"https://openalex.org/keywords/niemann-pick-disease-type-c","display_name":"Niemann-Pick disease type C","score":0.828000009059906},{"id":"https://openalex.org/keywords/gm2-gangliosidoses","display_name":"GM2 gangliosidoses","score":0.9860000014305115},{"id":"https://openalex.org/keywords/tay-sachs-disease","display_name":"Tay-Sachs disease","score":0.9980000257492065},{"id":"https://openalex.org/keywords/sandhoff-disease","display_name":"Sandhoff disease","score":1.0},{"id":"https://openalex.org/keywords/ataxia-telangiectasia","display_name":"ataxia telangiectasia","score":1.0},{"id":"https://openalex.org/keywords/orphan-drug-development","display_name":"orphan drug development","score":0.8539999723434448},{"id":"https://openalex.org/keywords/anchor-test","display_name":"anchor test","score":0.6549999713897705},{"id":"https://openalex.org/keywords/nine-hole-peg-test","display_name":"Nine-Hole Peg Test","score":0.9879999756813049},{"id":"https://openalex.org/keywords/disease-modifying-therapy","display_name":"disease-modifying therapy","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C2779390119","wikidata":"https://www.wikidata.org/wiki/Q917227","display_name":"Sandhoff disease","level":3,"score":0.856528639793396},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7393465042114258},{"id":"https://openalex.org/C75480439","wikidata":"https://www.wikidata.org/wiki/Q1367466","display_name":"Orphan drug","level":2,"score":0.7223697900772095},{"id":"https://openalex.org/C2779486608","wikidata":"https://www.wikidata.org/wiki/Q387082","display_name":"Ataxia-telangiectasia","level":4,"score":0.6673375964164734},{"id":"https://openalex.org/C2780906641","wikidata":"https://www.wikidata.org/wiki/Q213373","display_name":"Ataxia","level":2,"score":0.483782023191452},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.48247459530830383},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.46789705753326416},{"id":"https://openalex.org/C2780385302","wikidata":"https://www.wikidata.org/wiki/Q367158","display_name":"Protocol (science)","level":3,"score":0.4613634943962097},{"id":"https://openalex.org/C2779701055","wikidata":"https://www.wikidata.org/wiki/Q929833","display_name":"Rare disease","level":3,"score":0.42448562383651733},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.3830738663673401},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.3246394693851471},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.22409474849700928},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2211737036705017},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.20808479189872742},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.20523661375045776},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.14735651016235352},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.09783533215522766},{"id":"https://openalex.org/C552990157","wikidata":"https://www.wikidata.org/wiki/Q7430","display_name":"DNA","level":2,"score":0.0},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.0},{"id":"https://openalex.org/C143425029","wikidata":"https://www.wikidata.org/wiki/Q5205747","display_name":"DNA damage","level":3,"score":0.0}],"mesh":[{"descriptor_ui":"D001260","descriptor_name":"Ataxia Telangiectasia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007930","descriptor_name":"Leucine","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011788","descriptor_name":"Quality of Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000175","qualifier_name":"diagnosis","is_major_topic":true},{"descriptor_ui":"D019636","descriptor_name":"Neurodegenerative Diseases","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D020143","descriptor_name":"Gangliosidoses, GM2","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":7,"locations":[{"id":"doi:10.1186/s13063-020-05009-3","doi":"https://doi.org/10.1186/s13063-020-05009-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13063-020-05009-3","pdf_url":"https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-020-05009-3","source":{"id":"https://openalex.org/S109512841","display_name":"Trials","issn_l":"1745-6215","issn":["1745-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"journal-article"},{"id":"pmid:33482890","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/33482890","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"Journal Article"},{"id":"pmh:oai:pubmedcentral.nih.gov:7821839","doi":null,"is_oa":true,"landing_page_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7821839/","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"Text"},{"id":"pmh:oai:https://nottingham-repository.worktribe.com/:5273388","doi":null,"is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13063-020-05009-3","pdf_url":"https://nottingham-repository.worktribe.com/file/5273388/1/Fields%20Trials%202021","source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:nottingham-repository.worktribe.com:5273388","doi":null,"is_oa":true,"landing_page_url":"https://nottingham-repository.worktribe.com/5273388/1/Fields%20Trials%202021","pdf_url":"https://nottingham-repository.worktribe.com/preview/5273514/Fields%20Trials%202021.pdf","source":{"id":"https://openalex.org/S4306402483","display_name":"Repository@Nottingham (University of Nottingham)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I142263535","host_organization_name":"University of Nottingham","host_organization_lineage":["https://openalex.org/I142263535"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"Journal Article"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:84085647-f810-4c21-9553-c7ac056df86e","doi":null,"is_oa":true,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:84085647-f810-4c21-9553-c7ac056df86e","pdf_url":"https://ora.ox.ac.uk/objects/uuid:84085647-f810-4c21-9553-c7ac056df86e/files/sm326m242k","source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Symplectic Elements","raw_type":"Journal article"},{"id":"pmh:oai:doaj.org/article:7e79df41cea1412ebe6936c900bbe966","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/7e79df41cea1412ebe6936c900bbe966","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Trials, Vol 22, Iss 1, Pp 1-15 (2021)","raw_type":"article"}],"best_oa_location":{"id":"doi:10.1186/s13063-020-05009-3","doi":"https://doi.org/10.1186/s13063-020-05009-3","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13063-020-05009-3","pdf_url":"https://trialsjournal.biomedcentral.com/counter/pdf/10.1186/s13063-020-05009-3","source":{"id":"https://openalex.org/S109512841","display_name":"Trials","issn_l":"1745-6215","issn":["1745-6215"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-class-a","anvur-scientific","cwts-core","doaj","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-100","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Trials","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[{"display_name":"Study Protocol","id":"https://openalex.org/study-designs/study-protocol"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307025","display_name":"National Ataxia Foundation","ror":"https://ror.org/03s9xxw55"},{"id":"https://openalex.org/F4320307375","display_name":"National Niemann-Pick Disease Foundation","ror":"https://ror.org/05v6a8j46"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320308970","display_name":"Teva Pharmaceutical Industries","ror":"https://ror.org/01wfv3m53"},{"id":"https://openalex.org/F4320317499","display_name":"Bundesinstitut f\u00fcr Arzneimittel und Medizinprodukte","ror":"https://ror.org/05ex5vz81"},{"id":"https://openalex.org/F4320320050","display_name":"Ataxia UK","ror":"https://ror.org/03192vt15"},{"id":"https://openalex.org/F4320321644","display_name":"College ter Beoordeling van Geneesmiddelen","ror":"https://ror.org/041evnj42"},{"id":"https://openalex.org/F4320322148","display_name":"Eisai","ror":"https://ror.org/04vvh7p27"},{"id":"https://openalex.org/F4320333587","display_name":"Sanofi Genzyme","ror":null},{"id":"https://openalex.org/F4320338282","display_name":"Actelion Pharmaceuticals","ror":"https://ror.org/001yedb91"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W3121664580.pdf","grobid_xml":"https://content.openalex.org/works/W3121664580.grobid-xml"},"referenced_works_count":34,"referenced_works":["https://openalex.org/W1538679591","https://openalex.org/W1973196456","https://openalex.org/W1994873004","https://openalex.org/W2024393233","https://openalex.org/W2036647635","https://openalex.org/W2055847326","https://openalex.org/W2059094083","https://openalex.org/W2061736826","https://openalex.org/W2083930723","https://openalex.org/W2086233417","https://openalex.org/W2095560475","https://openalex.org/W2096145249","https://openalex.org/W2106425927","https://openalex.org/W2108116414","https://openalex.org/W2113755495","https://openalex.org/W2129415962","https://openalex.org/W2138034498","https://openalex.org/W2143759122","https://openalex.org/W2148083007","https://openalex.org/W2160604070","https://openalex.org/W2199236088","https://openalex.org/W2325050736","https://openalex.org/W2397368147","https://openalex.org/W2726405642","https://openalex.org/W2726866384","https://openalex.org/W2747410013","https://openalex.org/W2788702966","https://openalex.org/W2885654157","https://openalex.org/W2886544055","https://openalex.org/W2982366500","https://openalex.org/W2988630324","https://openalex.org/W3007100847","https://openalex.org/W3024300525","https://openalex.org/W3157386383"],"related_works":["https://openalex.org/W6901879984","https://openalex.org/W6939731857","https://openalex.org/W4378716833","https://openalex.org/W3189943578","https://openalex.org/W4394600875","https://openalex.org/W3202042235","https://openalex.org/W4310593690","https://openalex.org/W7127429627","https://openalex.org/W7164153049","https://openalex.org/W4400986842"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1,113,169,225,247,345,397,437],"lack":[2],"of":[3,9,14,18,49,64,137,155,159,163,176,186,214,260,271,276,285,300,306,327,353,386,399,428],"approved":[4],"treatments":[5,51,430],"for":[6,40,90,197,369,411,425,431,441,448,455],"the":[7,15,33,47,62,75,130,138,148,156,173,182,193,205,215,243,261,269,274,282,288,301,304,307,322,363,383,393,426],"majority":[8],"rare":[10,42],"diseases":[11],"is":[12,153,250,330,356,366,372,407],"reflective":[13],"unique":[16,222],"challenges":[17],"orphan":[19,433],"drug":[20],"development.":[21],"Novel":[22],"methodologies,":[23],"including":[24],"new":[25,422],"functionally":[26,367],"relevant":[27,368],"endpoints,":[28],"are":[29,228],"needed":[30],"to":[31,52,73,237,242,281,316,374,382],"render":[32],"development":[34,63,427],"process":[35],"more":[36],"feasible":[37],"and":[38,44,69,104,108,118,141,161,189,273,311,324,340,391,414,416,452,472],"appropriate":[39],"these":[41,166,400],"populations":[43],"thereby":[45],"expedite":[46],"approval":[48],"promising":[50],"address":[53],"patients'":[54,384],"high":[55],"unmet":[56],"medical":[57],"need.":[58],"Here,":[59],"we":[60],"describe":[61],"an":[65,291,408],"innovative":[66,114],"master":[67,116],"protocol":[68,117],"primary":[70,121,171,201,262,364,394],"outcome":[71,395],"assessment":[72,249],"investigate":[74,320],"modified":[76],"amino":[77],"acid":[78],"N-acetyl-L-leucine":[79,329,406],"(Sponsor":[80],"Code:":[81],"IB1001)":[82],"in":[83,165,178,230,303,358],"three":[84,91,266,401,438],"separate,":[85],"multinational,":[86],"phase":[87],"II":[88],"trials":[89,402,439],"ultra-rare,":[92],"autosomal-recessive,":[93],"neurodegenerative":[94],"disorders:":[95],"Niemann-Pick":[96,442],"disease":[97,443],"type":[98,444],"C":[99,445],"(NPC),":[100,446],"GM2":[101,449],"gangliosidoses":[102,450],"(Tay-Sachs":[103,451],"Sandhoff":[105],"disease;":[106],"\"GM2\"),":[107],"ataxia":[109,456],"telangiectasia":[110,457],"(A-T).":[111],"METHODS/DESIGN:":[112],"IB1001":[115],"novel":[119,170,346],"CI-CS":[120,248,347],"endpoints":[122],"were":[123],"developed":[124,349],"through":[125,350],"a":[126,146,200,231,277,296,336,351,421],"close":[127],"collaboration":[128,352],"between":[129],"Industry":[131],"Sponsor,":[132],"Key":[133],"Opinion":[134],"Leaders,":[135],"representatives":[136],"Patient":[139],"Communities,":[140],"National":[142],"Regulatory":[143],"Authorities.":[144],"As":[145],"result,":[147],"open-label,":[149],"rater-blinded":[150],"study":[151,339],"design":[152],"considerate":[154],"practical":[157],"limitations":[158],"recruitment":[160],"retention":[162],"subjects":[164],"ultra-orphan":[167],"populations.":[168],"endpoint,":[172],"Clinical":[174],"Impression":[175],"Change":[177],"Severity\u00a9":[179],"(CI-CS),":[180],"accommodates":[181],"heterogenous":[183],"clinical":[184,223,379],"presentation":[185],"NPC,":[187,412],"GM2,":[188,413],"A-T:":[190],"at":[191,234,462],"screening,":[192],"principal":[194],"investigator":[195],"appoints":[196],"each":[198,235,286,370],"patient":[199],"anchor":[202,226,263],"test":[203,208,213,264],"(either":[204],"8-m":[206],"walk":[207],"(8MWT)":[209],"or":[210],"9-hole":[211],"peg":[212],"dominant":[216],"hand":[217],"(9HPT-D))":[218],"based":[219],"on":[220,295],"his/her":[221],"symptoms.":[224],"tests":[227],"videoed":[229],"standardized":[232],"manner":[233],"visit":[236],"capture":[238,375],"all":[239,354],"aspects":[240],"related":[241],"patient's":[244,308],"functional":[245],"performance.":[246],"ultimately":[251],"performed":[252],"by":[253],"independent,":[254],"blinded":[255],"raters":[256,289],"who":[257],"compare":[258],"videos":[259],"from":[265,313],"periods:":[267],"baseline,":[268],"end":[270,275],"treatment,":[272,328],"post-treatment":[278],"washout.":[279],"Blinded":[280],"time":[283],"point":[284],"video,":[287],"make":[290],"objective":[292],"comparison":[293],"scored":[294],"7-point":[297],"Likert":[298],"scale":[299],"change":[302],"severity":[305],"neurological":[309],"signs":[310],"symptoms":[312],"video":[314,317],"A":[315],"B.":[318],"To":[319],"both":[321],"symptomatic":[323],"disease-modifying":[325],"effects":[326],"assessed":[331],"during":[332],"two":[333],"treatment":[334,410],"sequences:":[335],"6-week":[337],"parent":[338],"1-year":[341],"extension":[342],"phase.":[343],"DISCUSSION:":[344],"assessment,":[348],"stakeholders,":[355],"advantageous":[357],"that":[359],"it":[360],"better":[361],"ensures":[362],"endpoint":[365],"patient,":[371],"able":[373],"small":[376],"but":[377],"meaningful":[378],"changes":[380],"critical":[381],"quality":[385],"life":[387],"(fine-motor":[388],"skills;":[389],"gait),":[390],"blinds":[392],"assessment.":[396],"results":[398],"will":[403],"inform":[404],"whether":[405],"effective":[409],"A-T":[415],"can":[417],"also":[418],"serve":[419],"as":[420],"therapeutic":[423],"paradigm":[424],"future":[429],"other":[432],"diseases.":[434],"TRIAL":[435],"REGISTRATION:":[436],"(IB1001-201":[440],"IB1001-202":[447],"Sandhoff),":[453],"IB1001-203":[454],"(A-T))":[458],"have":[459],"been":[460],"registered":[461],"www.clinicaltrials.gov":[463],"(NCT03759639;":[464],"NCT03759665;":[465],"NCT03759678),":[466],"www.clinicaltrialsregister.eu":[467],"(EudraCT:":[468],"2018-004331-71;":[469],"2018-004406-25;":[470],"2018-004407-39),":[471],"https://www.germanctr.de":[473],"(DR":[474],"KS-ID:":[475],"DRKS00016567;":[476],"DRKS00017539;":[477],"DRKS00020511).":[478]},"counts_by_year":[{"year":2026,"cited_by_count":6},{"year":2025,"cited_by_count":3},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":12},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5}],"updated_date":"2026-11-10T11:39:43.021295","created_date":"2021-02-01T00:00:00"}